Share Price | Triochem Products Ltd Stock Analysis & Recommendation

Q: What does Triochem Product do?

Overview:Triochem Products Ltd is engaged in the manufacturing and exporting of pharmaceutical products, APIs, and chemicals, operating within the Pharmaceuticals & Biotechnology industry and classified as a Micro Cap company.History:The company was incorporated on January 17, 1972. The latest quarterly results reported are for March 2025, during which the company recorded a net profit.Financial Snapshot:Most recent Net Sales: N/AMost recent Net Profit: -4 Cr (Quarterly Results - Mar 2025)Market-cap value: INR Cr (Micro Cap)Key Metrics:Industry P/E: N/ADividend Yield: 0.00%Debt Equity: 0.00Return on Equity: 0.00%Price to Book: 0.00Contact Details:Address: Sambhava Chambers, 4th Floor Sir P M Road Mumbai Maharashtra : 400001Phone: 91-22-22663150Email: investor@triochemproducts.comWebsite: http://www.triochemproducts.com

Q: Who are the top shareholders of the Triochem Product?

The top shareholders of Triochem Product include the promoters, with Rajesh Ramu Deora holding the largest share at 14.69%. Additionally, Ambernath Plasto Packaging Private Limited is the highest public shareholder, owning 4.9%. Individual investors collectively hold 15.53% of the shares. There are currently no mutual funds or foreign institutional investors holding shares in the company.

Q: Why is Triochem Products Ltd falling/rising?

As of 02-Jun, the stock price of Triochem Products Ltd is currently at 17.40, with no change from the previous trading session (0.00%). The stock has shown a performance of 0.00% over the past week, month, and year, indicating a lack of movement in its price. In contrast, the benchmark Sensex has declined by 1.79% over the past week and 2.94% over the past month, suggesting that while Triochem Products Ltd is not rising, it is also not falling as sharply as the broader market.However, the stock has underperformed its sector significantly today, with a performance gap of -99.34%. Additionally, it has not traded on 5 out of the last 20 days, indicating erratic trading behavior. The stock is also trading lower than its moving averages across various time frames (5 day, 20 day, 50 day, 100 day, and 200 day), which typically signals a bearish trend.Despite the BSE Small Cap index gaining by 1.42%, Triochem Products Ltd's liquidity remains low, as it is only liquid enough for a trade size of Rs 0 cr based on 2% of the 5-day average traded value. This combination of factors suggests that the stock is not experiencing upward momentum and is instead stagnating or potentially declining in the context of market performance.

Results Declared: Triochem Product has declared results on 30 May 2026! Click here to unlock the latest financial performance

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

68.65%

When is the next results date for Triochem Product?

16-May-2025

No Upcoming Board Meetings

Who are in the management team of Triochem Product?

16-Jul-2025

As of March 2023, the management team of Triochem Product includes Ramu S Deora (CEO), Sunil S Jhunjhunwala (Independent Director), S S Sharma (Director), Girish Kumar Pungalia (Independent Director), Rajesh Ramu Deora (Director), Ureca Shirish Shirole (Company Secretary), and Grace R. Deora (Non-Executive Director). Each member contributes to the company's governance and operations.

View full answer

What does Triochem Product do?

17-Jul-2025

Triochem Products Ltd manufactures and exports pharmaceutical products, APIs, and chemicals, operating as a Micro Cap company. As of March 2025, it reported a net profit of -4 Cr.

View full answer

Who are the top shareholders of the Triochem Product?

17-Jul-2025

The top shareholders of Triochem Product include Rajesh Ramu Deora with 14.69%, Ambernath Plasto Packaging Private Limited at 4.9%, and individual investors holding a combined 15.53%. There are no mutual funds or foreign institutional investors currently involved.

View full answer

Why is Triochem Products Ltd falling/rising?

03-Jun-2026

As of 02-Jun, the stock price of Triochem Products Ltd is at 17.40, showing no change and a lack of movement over the past week, month, and year. Despite the broader market's decline, the stock has underperformed significantly within its sector and exhibits low liquidity and bearish trends.

View full answer

Which are the latest news on Triochem Product?

03-Jun-2026

No latest news for Triochem Product found.

Compare Triochem Product with Similar Stocks

Shyama Computro.Fabino Enter Brawn Biotech

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR Cr (Micro Cap)

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.00

Return on Equity

0.00%

Price to Book

0.00

Revenue and Profits:

Net Sales:

(Quarterly Results - Mar 2026)

Net Profit:

8 Cr

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication

01-Jun-2026 | Source : BSE

Audited Financial Result for the quarter and year ended 31st March 2026 in newspaper

Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32(1) Of The SEBI (Listing Obligation & Disclosures Requirement) Regulation 2015 For The Quarter Ended 31St March 2026.

29-May-2026 | Source : BSE

We hereby confirm that the Company has not raised / made offers by way of Public Issue Rigth Issue Preferential Issure Qualified Institutions Placement (QIP) etc. therefore for the quarter ended on 31st March 2026 is not applicable to our Company

Submission Of Audited Financial Results For The Quarter And Year Ended 31St March 2026

29-May-2026 | Source : BSE

Audited Financial Results of the Company for the Quarter / Year Ended 31st March 2026 duly Reviewed by the Audi Committee along with Declaration is given in compliance to Regulation 30(3)(d) of the SEBI (LODR) Regulation 2015...

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

No Data Found

Valuation key factors

No Data Found

Technicals key factors

Indicator

Weekly

Monthly

Technical indicator has not been calculated since the stock has been active for a short period

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Rajesh Ramu Deora (14.69%)

Highest Public shareholder

Triochem Laboratories Private Limited (4.9%)

Individual Investors Holdings

15.53%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 6,507.69% vs 31.58% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.22",
          "val2": "-0.38",
          "chgp": "42.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.08",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "11.17",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.33",
          "val2": "-0.13",
          "chgp": "6,507.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -83.33% vs 89.38% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.78",
          "val2": "-0.60",
          "chgp": "-30.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.22",
          "val2": "-0.12",
          "chgp": "-83.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -1,066.67% vs 97.74% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.16",
          "val2": "-1.19",
          "chgp": "2.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.35",
          "val2": "-0.03",
          "chgp": "-1,066.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 2,092.50% vs 60.40% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.38",
          "val2": "-1.22",
          "chgp": "-13.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.08",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "11.17",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "7.97",
          "val2": "-0.40",
          "chgp": "2,092.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.22

-0.38

42.11%

Interest

0.08

0.00

Exceptional Items

11.17

0.00

Standalone Net Profit

8.33

-0.13

6,507.69%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 6,507.69% vs 31.58% in Dec 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.78

-0.60

-30.00%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.22

-0.12

-83.33%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024

Standalone Net Profit

Growth in half year ended Sep 2025 is -83.33% vs 89.38% in Sep 2024

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-1.16

-1.19

2.52%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.35

-0.03

-1,066.67%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -1,066.67% vs 97.74% in Dec 2024

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-1.38

-1.22

-13.11%

Interest

0.08

0.00

Exceptional Items

11.17

0.00

Standalone Net Profit

7.97

-0.40

2,092.50%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

Standalone Net Profit

YoY Growth in year ended Mar 2026 is 2,092.50% vs 60.40% in Mar 2025

All Annual Results

Company CV

About Triochem Products Ltd

Triochem Products Ltd

Micro Cap

Pharmaceuticals & Biotechnology

Triochem Products Ltd was incorporated in the year January 17, 1972. The Company is engaged in the business of manufacturer and exporter of pharmaceuticals products, API and chemicals.

Company Coordinates

Company Details

Sambhava Chambers, 4th Floor Sir P M Road Mumbai Maharashtra : 400001

Tel: 91-22-22663150

http://www.triochemproducts.com

investor@triochemproducts.com

Registrar Details

Sharex (India) Pvt Ltd , Unit No.1, Luthra Ind.Premises Andheri Kurla Road, Safed Pool , Mumbai